CATHY-ANN CARBY: Open Payments
NPI 1568181303 · WABASH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 21 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $410
Food & beverage: $303Education: $107
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $141 |
| Axsome Therapeutics, Inc. | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| ABBVIE INC. | 3 | $49 |
| Alkermes, Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: Auvelity, FANAPT, REXULTI, VRAYLAR, HETLIOZ, ARISTADA, Qelbree.
Industry payments across IN — which companies pay providers there.
